Guo Aijie, Wang Feihu, Lin Wentao, Xu Xiaofen, Tang Tingting, Shen Yuanyuan, Guo Shengrong
School of Pharmacy, Shanghai Jiao Tong University, 800th Dongchuan Road, Shanghai 200240, China.
Shanghai Key Laboratory of Orthopaedic Implant, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China.
Int J Biol Macromol. 2014 Jun;67:163-71. doi: 10.1016/j.ijbiomac.2014.03.024. Epub 2014 Mar 25.
N-phosphonium chitosans (NPCSs) with different degrees of substitution (3%, 13% and 21%) were synthesized and evaluated as novel polymeric antibacterial agents. Their antibacterial activities compared with hydroxypropyltrimethyl ammonium chloride chitosan (HACC), parent chitosan and (5-carboxypentyl) triphenylphosphonium bromide (CTPB) were tested against Escherichia coli and two strains of drug-resistance Staphylococcus aureus by minimal inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and biofilm prevention assays. The results show that the NPCS with 3% or 13% substitution has lower MIC and MBC values and stronger ability to inhibit biofilm formation of all the three bacteria than HACC, chitosan and CTPB. In addition, the antibacterial activity of NPCSs increases with their substitution decreasing from 21% to 3%. Overall, the antibacterial activity of NPCS with 3% or 13% substitution is better than that of NPCS with 21% substitution, HACC with 22% substitution, chitosan and CTPB. It can be considered that NPCS with appropriate degree of substitution has favorable antibacterial activity and is a potential polymeric antibacterial agent.
合成了不同取代度(3%、13%和21%)的N-鏻壳聚糖(NPCS),并将其作为新型高分子抗菌剂进行评估。通过最小抑菌浓度(MIC)、最小杀菌浓度(MBC)和生物膜预防试验,测试了它们与羟丙基三甲基氯化铵壳聚糖(HACC)、母体壳聚糖和(5-羧基戊基)三苯基溴化鏻(CTPB)相比,对大肠杆菌和两株耐药金黄色葡萄球菌的抗菌活性。结果表明,取代度为3%或13%的NPCS比HACC、壳聚糖和CTPB具有更低的MIC和MBC值,以及更强的抑制所有三种细菌生物膜形成的能力。此外,NPCS的抗菌活性随着其取代度从21%降至3%而增强。总体而言,取代度为3%或13%的NPCS的抗菌活性优于取代度为21%的NPCS、取代度为22%的HACC、壳聚糖和CTPB。可以认为,具有适当取代度的NPCS具有良好的抗菌活性,是一种潜在的高分子抗菌剂。